Coverage
Transparency also means reporting on other peoples’ views of us
The Research Coverage and published analysis reports are an important tool for investors to evaluate a security in terms of the expected profitability of a company and the resulting share price opportunities. Seven banks and investment houses are currently observing the INDUS share and publishing regular research reports.
This is how our financial analysts currently rate us:
| Institute | Analyst | Status | Recommendation | Document | |
|---|---|---|---|---|---|
| FMR | Dr. Mohamad Vaseghi | Apr. 2024 | buy | 44.30 € | Download |
| Kepler Cheuvreux | Ludovic Allègre | Mar. 2024 | hold | 24.00 € | – |
| LBBW | Volker Stoll | Mar. 2024 | buy | 29.00 € | Download |
| M.M.Warburg | Felix Ellmann | Mar. 2024 | buy | 37.00 € | Download |
| NuWays | Christian Sandherr | Mar. 2024 | buy | 36.00 € | Download |
| ODDO BHF | Fabian Sémon | Feb. 2024 | outperform | 27.00 € | – |
| Pareto | Zafer Rüzgar | Mar. 2024 | buy | 40.00 € | – |
Seven banks and investment houses are watching INDUS Holding AG. | |||||
Consensus observational banks and investment firms:
INDUS has updated the INDUS Holding AG collects securities analysts’ estimates for selected key financial figures of the INDUS Group at sporadic intervals. INDUS also assumes no liability for the accuracy, completeness and correctness of these estimates and undertakes no obligation to update or revise the estimates.
Consensus as of 11th of April 2024
| In EUR Million | Average | Low | High | Estimates |
|---|---|---|---|---|
| 2024 | ||||
| Revenue | 1,876.3 | 1,835.0 | 1,919.0 | 6 |
| EBITDA | 243.2 | 230.0 | 258.5 | 6 |
| Operating earnings (EBIT) | 158.4 | 150.0 | 165.7 | 6 |
| EBT | 138.8 | 133.0 | 141.0 | 5 |
| Net income | 89.6 | 79.0 | 98.5 | 6 |
| Earnings per shares (EPS) | 3.35 | 2.96 | 3.77 | 6 |
| Dividend per share (DPS) | 1.35 | 1.15 | 1.70 | 6 |
| Free cash flow | 94.5 | 66.0 | 113.0 | 5 |
| Price Target | 35.05 | 24.00 | 44.30 | 6 |
